Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HERAMED LIMITED Capital/Financing Update 2020

Jun 24, 2020

65062_rns_2020-06-24_28110ccd-382d-487b-9ca4-19bc77ec3801.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [99 x 58] intentionally omitted <==

ACN 626 295 314

25 June 2020

Share Purchase Plan Update

Further to the announcement made by the Company (refer to the ASX announcement on 12 June 2020) regarding the Company’s share purchase plan (“ SPP ”), the Company advises that the closing date for the offer under the SPP (“ SPP Offer ”) has been extended by 13 days to 5:00pm (EST) on Thursday,9 July 2020.

The SPP will provide eligible shareholders with an opportunity to acquire up to A$30,000 worth of fully paid ordinary shares in the Company at an issue price of A$0.09 per share (“ New Shares ”) to raise up to A$1.5 million. The extension is to provide shareholders with more time to consider and subscribe for shares under the SPP. If you are an eligible shareholder and haven’t received an application form - and wish to participate in the SPP Offer, please contact the Company Secretary Jonathan@hera med.com.

Detailed below is an updated timetable for the SPP Offer incorporating the extended closing date.

Event Date*
Record Date to identify eligible shareholdersentitled to participate in the SPP Offer 7:00pm (EST) on Friday, 29 May 2020
Opening Date of the SPP Offer Friday, 12 June 2020
Closing Date of the SPP Offer 5:00pm (EST) Thursday, 9 July 2020
Announcement of SPP Results Monday, 13 July 2020
Annual General Meeting 4:00pm (EST) Tuesday, 14 July 2020
Completion of the allotment and issue of NewShares under the SPP Offer 15 July 2020

The above dates are indicative only and are subject to the Listing Rules. The Company reserves the right to further vary these dates.

This announcement is authorised for market release by the board of Directors of HeraMED Limited.

Yours sincerely

Jonathan Hart Company Secretary

HeraMED Limited ACN 626 295 314 T: +61 2 8379 2961 | A: Suite 3, Level 10, 23-25 Hunter Street SYDNEY NSW 2000